Cargando…
Translational tidbits
Merck KGaA enters the tankyrase race; Pluristem joins with Case Western to test its new cell therapy; Astellas' AIM unit targets Boston for innovation; the White House clamps down on gain-of-function studies; a round-up of public-private partnerships.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149064/ http://dx.doi.org/10.1038/scibx.2014.1282 |